📣 VC round data is live. Check it out!

Dentsply Sirona Valuation Multiples

Discover revenue and EBITDA valuation multiples for Dentsply Sirona and similar public comparables like Inner Mongolia Furui Medical Science, Shandong Weigao Blood, Chengzhi, Ansell and more.

Dentsply Sirona Overview

About Dentsply Sirona

Dentsply Sirona is one of the world’s largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm’s wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm’s salesforce or directly to consumers (such as the Byte clear aligner).


Founded

1983

HQ

United States

Employees

14.0K

Financials (LTM)

Revenue: $4B
EBITDA: $643M

EV

$4B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Dentsply Sirona Financials

Dentsply Sirona reported last 12-month revenue of $4B and EBITDA of $643M.

In the same LTM period, Dentsply Sirona generated $2B in gross profit, $643M in EBITDA, and $306M in net income.

Revenue (LTM)


Dentsply Sirona P&L

In the most recent fiscal year, Dentsply Sirona reported revenue of $4B and EBITDA of $667M.

Dentsply Sirona is profitable as of last fiscal year, with gross margin of 50%, EBITDA margin of 18%, and net margin of 9%.

See analyst estimates for Dentsply Sirona
LTMLast FY202320242025202620272028
Revenue$4B$4B$4B$4B$4B
Gross Profit$2B$2B$2B$2B$2B
Gross Margin52%50%53%52%50%
EBITDA$643M$667M$249M($518M)($46M)
EBITDA Margin18%18%6%(14%)(1%)
EBIT Margin13%14%7%5%7%
Net Profit$306M$320M($132M)($910M)($598M)
Net Margin8%9%(3%)(24%)(16%)
Net Debt—$2B———

Financial data powered by Morningstar, Inc.

Dentsply Sirona Stock Performance

Dentsply Sirona has current market cap of $2B, and enterprise value of $4B.

Market Cap Evolution


Dentsply Sirona's stock price is $10.20.

Dentsply Sirona share price decreased by 13.1% in the last 30 days, and by 36.1% in the last year.

Dentsply Sirona has an EPS (earnings per share) of $1.60.

See more trading valuation data for Dentsply Sirona
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$4B$2B2.8%-13.1%-30.5%-36.1%$1.60

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Dentsply Sirona Valuation Multiples

Dentsply Sirona trades at 1.1x EV/Revenue multiple, and 6.5x EV/EBITDA.

See NTM and 2027E valuation multiples for Dentsply Sirona

EV / Revenue (LTM)


Dentsply Sirona Financial Valuation Multiples

As of May 23, 2026, Dentsply Sirona has market cap of $2B and EV of $4B.

Dentsply Sirona has a P/E ratio of 6.7x.

LTMLast FY202320242025202620272028
EV/Revenue1.1x1.1x1.1x1.1x1.1x
EV/EBITDA6.5x6.3x16.8x(8.1x)(91.0x)
EV/EBIT8.7x8.2x14.8x22.3x16.6x
EV/Gross Profit2.2x2.3x2.0x2.1x2.3x
P/E6.7x6.4x(15.5x)(2.2x)(3.4x)
EV/FCF28.6x40.2x18.4x14.9x40.2x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Dentsply Sirona Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Dentsply Sirona Margins & Growth Rates

Dentsply Sirona decreased revenue by 3% and EBITDA by 9% in the last fiscal year.

In the most recent fiscal year, Dentsply Sirona reported gross margin of 50%, EBITDA margin of 18%, and net margin of 9%.

See estimated margins and future growth rates for Dentsply Sirona

Dentsply Sirona Margins

Last FY202420252026202720282029
Gross Margin50%52%50%52%
EBITDA Margin18%(14%)(1%)17%
EBIT Margin14%5%7%12%
Net Margin9%(24%)(16%)8%
FCF Margin3%7%3%6%

Dentsply Sirona Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth(3%)(4%)(3%)(3%)
Gross Profit Growth2%(6%)(6%)2%
EBITDA Growth(9%)(308%)(91%)(1416%)
EBIT Growth(13%)(33%)34%75%
Net Profit Growth(11%)589%(34%)(148%)
FCF Growth104%23%(63%)104%

Data powered by FactSet, Inc. and Morningstar, Inc.

Dentsply Sirona Operational KPIs

Dentsply Sirona's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.

Dentsply Sirona's Rule of 40 is 14% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Dentsply Sirona's Rule of X is 10% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Dentsply Sirona
LTMLast FY202320242025202620272028
Rule of 4017%14%———
Bessemer Rule of X16%10%———
Revenue per Employee—$0.3M———
Opex per Employee—$0.1M———
G&A Expenses to Revenue——41%——
R&D Expenses to Revenue4%4%5%4%4%
Opex to Revenue—43%45%47%43%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Dentsply Sirona Competitors

Dentsply Sirona competitors include Inner Mongolia Furui Medical Science, Shandong Weigao Blood, Chengzhi, Ansell, Kestra Medical Technologies, Shinva, Schott Pharma, BioLife Solutions, Sopharma and Haemonetics.

Most Dentsply Sirona public comparables operate across Medical Supplies.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Inner Mongolia Furui Medical Science8.8x8.0x30.7x32.4x
Shandong Weigao Blood3.2x3.1x14.5x14.5x
Chengzhi1.4x—16.6x—
Ansell1.6x1.6x9.1x8.3x
Kestra Medical Technologies17.0x10.7x(12.8x)(12.2x)
Shinva0.6x0.6x7.0x6.9x
Schott Pharma2.6x2.6x8.9x9.3x
BioLife Solutions11.5x10.7x44.5x41.2x

This data is available for Pro users. Sign up to see all Dentsply Sirona competitors and their valuation data.

Start Free Trial

Dentsply Sirona M&A Activity

Dentsply Sirona has acquired 6 companies to date.

Last acquisition by Dentsply Sirona was on June 1st 2021. Dentsply Sirona acquired PROPEL Orthodontics for $132M (EV/Revenue multiple of ).

See M&A valuation multiples

Latest Acquisitions by Dentsply Sirona

PROPEL Orthodontics
byte
OraMetrix
Recherche Techniques Dentaires
Description
PROPEL Orthodontics is a medical device manufacturer offering tools for orthodontic acceleration. Its flagship PROPEL Envelope device uses micro-perforations to stimulate bone remodeling and reduce treatment time by up to 60 percent for braces and aligners. The Milpitas, California-headquartered company also provides the PROPEL Harmony system for accelerated orthodontics. PROPEL products target orthodontists seeking minimally invasive alveolar micro-osteoperforation techniques.
Byte offers at-home clear aligner treatments prescribed via teledentistry. Los Angeles-headquartered, the service connects patients to a nationwide network of orthodontists for custom HyperByte plans that straighten teeth in months. The subscription model starts under $85 monthly, including aligners, retainers, and remote monitoring.
OraMetrix is a Richardson, Texas-headquartered firm founded in 1998 offering 3D orthodontic solutions. Its SureSmile system provides digital treatment planning, archwire fabrication, and monitoring via intraoral scanners. With an office in Berlin, Germany, OraMetrix supports orthodontists treating over 2 million patients annually worldwide.
Recherche Techniques Dentaires is a Vienne-based leader in fiber-reinforced composite dental posts for endodontics. Certified to ISO 9001 and EN 13485 standards, the company holds multiple patents on its products including the original Composipost introduced in 1988 with long pre-tensed carbon fibers. RTD supplies a range of posts from quartz and glass fibers for permanent restorations worldwide, evolving from 1986 carbon fiber temporaries to high-performance epoxy composites.
HQ CountryUnited StatesUnited StatesUnited StatesFrance
HQ City
San Jose, CA
Los Angeles, CA
Dallas, TX
Dijon
Deal Date1 Jun 20214 Jan 202126 Mar 201830 Mar 2017
Valuation$132M$1Bundisclosed$132M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Dentsply Sirona acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Dentsply Sirona

When was Dentsply Sirona founded?Dentsply Sirona was founded in 1983.
Where is Dentsply Sirona headquartered?Dentsply Sirona is headquartered in United States.
How many employees does Dentsply Sirona have?As of today, Dentsply Sirona has over 14K employees.
Who is the CEO of Dentsply Sirona?Dentsply Sirona's CEO is Daniel T. Scavilla.
Is Dentsply Sirona publicly listed?Yes, Dentsply Sirona is a public company listed on Nasdaq.
What is the stock symbol of Dentsply Sirona?Dentsply Sirona trades under XRAY ticker.
When did Dentsply Sirona go public?Dentsply Sirona went public in 1983.
Who are competitors of Dentsply Sirona?Dentsply Sirona main competitors include Inner Mongolia Furui Medical Science, Shandong Weigao Blood, Chengzhi, Ansell, Kestra Medical Technologies, Shinva, Schott Pharma, BioLife Solutions, Sopharma, Haemonetics.
What is the current market cap of Dentsply Sirona?Dentsply Sirona's current market cap is $2B.
What is the current revenue of Dentsply Sirona?Dentsply Sirona's last 12 months revenue is $4B.
What is the current revenue growth of Dentsply Sirona?Dentsply Sirona revenue growth (NTM/LTM) is (1%).
What is the current EV/Revenue multiple of Dentsply Sirona?Current revenue multiple of Dentsply Sirona is 1.1x.
Is Dentsply Sirona profitable?Yes, Dentsply Sirona is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Dentsply Sirona?Dentsply Sirona's last 12 months EBITDA is $643M.
What is Dentsply Sirona's EBITDA margin?Dentsply Sirona's last 12 months EBITDA margin is 18%.
What is the current EV/EBITDA multiple of Dentsply Sirona?Current EBITDA multiple of Dentsply Sirona is 6.5x.
What is the current FCF of Dentsply Sirona?Dentsply Sirona's last 12 months FCF is $146M.
What is Dentsply Sirona's FCF margin?Dentsply Sirona's last 12 months FCF margin is 4%.
What is the current EV/FCF multiple of Dentsply Sirona?Current FCF multiple of Dentsply Sirona is 28.6x.
How many companies Dentsply Sirona has acquired to date?As of May 2026, Dentsply Sirona has acquired 6 companies.
What was the largest acquisition by Dentsply Sirona?$11B acquisition of Sirona Dental System on 16th September 2015 was the largest M&A Dentsply Sirona has done to date.
What companies Dentsply Sirona acquired?Dentsply Sirona acquired Sirona Dental System, byte, MIS Implants Technologies, PROPEL Orthodontics, Recherche Techniques Dentaires, and OraMetrix.
In how many companies Dentsply Sirona has invested to date?Dentsply Sirona hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Dentsply Sirona

Lists including Dentsply Sirona

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial